🇬🇧 Retatrutide · United Kingdom

Buy Retatrutide in United Kingdom

Retatrutide (LY3437943) is a single-molecule triple receptor agonist that activates the GLP-1, GIP and glucagon receptors at once — the most recent and most studied entrant in the incretin class. New-U supplies it as a lyophilised research compound in 10-vial packs for laboratory study of incretin and glucagon-receptor signalling.

>99% purity, HPLC tested 10 vials per pack Tracked United Kingdom delivery Batch COA on every product

What is Retatrutide?

Retatrutide (LY3437943) is a single-molecule triple receptor agonist that activates the GLP-1, GIP and glucagon receptors at once — the most recent and most studied entrant in the incretin class. New-U supplies it as a lyophilised research compound in 10-vial packs for laboratory study of incretin and glucagon-receptor signalling.

Retatrutide in research

In published clinical research, retatrutide has reported the largest body-composition effects of any compound in the incretin family to date. New-U supplies retatrutide purely as a research chemical for in-vitro and laboratory work — these are descriptive research observations, not usage guidance, and New-U provides no human dosing recommendations.

Why researchers choose New-U Retatrutide

Every retatrutide batch is independently HPLC tested by Janoshik Analytics or Freedom Diagnostics to >99% purity, with mass-spectrometry identity confirmation and a batch-linked Certificate of Analysis on the product page. Supplied direct from the manufacturer in full 10-vial packs — no reseller mark-up, no relabelled stock.

Priced in USD; your local currency is applied at checkout.

How to buy Retatrutide in United Kingdom

Choose your Retatrutide pack

Open the Retatrutide product page — molecular weight, batch number and a downloadable Certificate of Analysis are shown up front. Packs ship as a full 10-vial research quantity, not single vials.

Check the Certificate of Analysis

Every batch is independently HPLC tested by Janoshik Analytics or Freedom Diagnostics. The COA shows identity, purity (>99%) and batch number — download it before ordering, not after.

Pay by card or crypto

Checkout accepts debit/credit cards and crypto. Prices settle in USD; your local currency is shown at checkout. Tracked United Kingdom delivery is a flat fee, free over the threshold.

Receive your tracked order

Orders ship within 24 hours, discreetly packed with cold-chain handling. Most United Kingdom orders arrive in roughly 6–14 business days with email + SMS tracking.

United Kingdom delivery & payment

Tracked United Kingdom delivery£25 flat · free over £300
£25 flat · free over £300Tracked United Kingdom delivery
Card & cryptoCard & crypto
RUOSupplied strictly for laboratory and research use — not for human use. 21+.
LondonManchesterBirminghamGlasgowLeedsBristol

Buying Retatrutide in United Kingdom — FAQ

What is retatrutide?

Retatrutide (LY3437943) is a triple GLP-1 / GIP / glucagon receptor agonist studied in metabolic research. New-U supplies it as a research chemical only — for laboratory and research use, not for human use.

What purity is New-U's retatrutide?

Every batch is independently HPLC tested to >99% purity with mass-spectrometry identity confirmation; the batch Certificate of Analysis is downloadable from the product page before you order.

Is retatrutide the same as a branded GLP-1 medicine?

No. Retatrutide is not an approved medicine and is not sold as one. New-U supplies it strictly as a research compound for laboratory use — not for human or veterinary use.

What pack sizes does retatrutide ship in?

Retatrutide ships in full 10-vial research packs across a range of mg strengths, direct from the manufacturer with a batch-linked COA.

Ready to buy Retatrutide in United Kingdom?

Retatrutide (LY3437943) is a single-molecule triple receptor agonist that activates the GLP-1, GIP and glucagon receptors at once — the most recent and most studied entrant in the incretin class. New-U supplies it as a lyophilised research compound in 10-vial packs for laboratory study of incretin and glucagon-receptor signalling.